# US 8,278,094 B2 · Bone semi-permeable device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,094 B2
- Document ID: US8278094B2
- Status: Granted
- Kind: B2
- Application number: 11/304,499
- Filed: 2005-12-14
- Published: 2007-06-14
- Granted: 2012-10-02
- Earliest claimed: 2005-12-14
- Assignees: The Invention Science Fund I, LLC
- Inventors: Ed Harlow; Edward K. Y. Jung; Robert Langer; Eric C. Leuthardt; Lowell L. Wood, Jr.
- Web page: https://patentgrep.com/patent/US8278094B2

## CPC

- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 47/6901: {Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors}
- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 27/3808: {Endothelial cells}
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 19/00: Drugs for skeletal disorders
- C12N 5/0654: {Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth}
- A61K 2035/126: {Immunoprotecting barriers, e.g. jackets, diffusion chambers}
- B33Y 80/00: Products made by additive manufacturing
- C12N 2510/00: Genetically modified cells
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING

## Abstract

Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects.

## Claims

### Claim 1

A method of assembling a device for delivering one or more biologically active molecules to a subject, comprising:
identifying the one or more biologically active molecules,
selecting a device comprising an implantable bone structure having a semi-permeable component and a bone cage comprising living bone cells wherein the bone cage partially forms an internal cavity, wherein the semi-permeable component comprises a layer of confluent cells, and
providing the one or more biologically active molecules to the device.

### Claim 2 (depends on 1)

The method of claim 1, wherein the one or more biologically active molecules are produced by one or more living cells or tissues.

### Claim 3 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are at least partially enclosed by the semi-permeable component.

### Claim 4 (depends on 3)

The method of claim 3, wherein the semi-permeable component is at least partially surrounded by the implantable bone structure.

### Claim 5 (depends on 1)

The method of claim 1, wherein the semi-permeable component is autologous with respect to the subject.

### Claim 6 (depends on 1)

The method of claim 1, wherein the semi-permeable component is allogeneic with respect to the subject.

### Claim 7 (depends on 1)

The method of claim 1, wherein the semi-permeable component is xenogeneic with respect to the subject.

### Claim 8 (depends on 1)

The method of claim 1, wherein the semi-permeable component is genetically engineered.

### Claim 9 (depends on 1)

The method of claim 1, wherein the semi-permeable component is designed to at least partially prevent restructuring of the implantable bone structure.

### Claim 10 (depends on 1)

The method of claim 1, wherein the semi-permeable component is designed to at least partially enhance restructuring of the implantable bone structure.

### Claim 11 (depends on 1)

The method of claim 1, wherein the semi-permeable component is immunogenic with respect to the subject.

### Claim 12 (depends on 1)

The method of claim 1, wherein the semi-permeable component is non-immunogenic with respect to the subject.

### Claim 13 (depends on 1)

The method of claim 1, wherein the semi-permeable component is recognized as self by the subject.

### Claim 14 (depends on 1)

The method of claim 1, wherein the semi-permeable component at least partially surrounds the implantable bone structure.

### Claim 15 (depends on 1)

The method of claim 1, wherein the semi-permeable component surrounds the implantable bone structure.

### Claim 16 (depends on 1)

The method of claim 1, wherein the semi-permeable component at least partially surrounds the one or more biologically active molecules.

### Claim 17 (depends on 1)

The method of claim 1, wherein the semi-permeable membrane surrounds the one or more biologically active molecules.

### Claim 18 (depends on 1)

The method of claim 1, wherein the implantable bone structure at least partially surrounds the one or more biologically active molecules.

### Claim 19 (depends on 1)

The method of claim 1, wherein the implantable bone structure surrounds the one or more biologically active molecules.

### Claim 20 (depends on 1)

The method of claim 1, wherein the implantable bone structure at least partially surrounds the semi-permeable component.

### Claim 21 (depends on 1)

The method of claim 1, wherein the implantable bone structure surrounds the semi-permeable component.

### Claim 22 (depends on 3)

The method of claim 3, wherein the semi-permeable component is surrounded by the implantable bone structure.

### Claim 23 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are enclosed by the semi-permeable component.

### Claim 24 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are autologous with respect to the subject.

### Claim 25 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are allogeneic with respect to the subject.

### Claim 26 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are xenogeneic with respect to the subject.

### Claim 27 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are genetically engineered.

### Claim 28 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are non-immunogenic with respect to the subject.

### Claim 29 (depends on 2)

The method of claim 2, wherein the one or more living cells or tissues are immunogenic with respect to the subject.

### Claim 30 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of bone that is autologous with respect to the subject.

### Claim 31 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of bone that is allogeneic with respect to the subject.

### Claim 32 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of bone that is xenogeneic with respect to the subject.

### Claim 33 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of in vitro cultured bone cells.

### Claim 34 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of genetically engineered bone cells.

### Claim 35 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of bone cells differentiated from stem cells in vitro.

### Claim 36 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of artificial bone.

### Claim 37 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of organic bone.

### Claim 38 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of anorganic bone.

### Claim 39 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of demineralized bone.

### Claim 40 (depends on 1)

The method of claim 1, wherein the bone cage is comprised of freeze-dried bone.

### Claim 41 (depends on 1)

The method of claim 1, wherein the implantable bone structure is treated to at least partially prevent restructuring.

### Claim 42 (depends on 1)

The method of claim 1, wherein the implantable bone structure is designed to be at least partially restructured.

### Claim 43 (depends on 1)

The method of claim 1, wherein the implantable bone structure is at least partially resorbable.

### Claim 44 (depends on 1)

The method of claim 1, wherein the implantable bone structure is immunogenic with respect to the subject.

### Claim 45 (depends on 1)

The method of claim 1, wherein the implantable bone structure is non-immunogenic with respect to the subject.

### Claim 46 (depends on 1)

The method of claim 1, wherein the implantable bone structure is recognized as self by the subject.

### Claim 47 (depends on 1)

The method of claim 1, wherein the implantable bone structure is micromachined.

### Claim 48 (depends on 1)

The method of claim 1, wherein the subject is an animal.

### Claim 49 (depends on 48)

The method of claim 48, wherein the animal is selected from the group consisting of a domesticated animal, a farm animal, a marine animal, a sport animal, a wild animal, a research animal, a zoo animal, a bird, an amphibian, a reptile, a fish and a mammal.

### Claim 50 (depends on 49)

The method of claim 49, wherein the mammal is a human.

### Claim 51

A method of manufacturing an implantable device for delivering one or more biologically active molecules to a subject, comprising:
identifying the one or more biologically active molecules, wherein the one or more biologically active molecules are designed to at least partially modify bone restructuring,
selecting a device comprising an implantable bone having a semi-permeable component and a bone cage comprising living bone cells wherein the bone cage at least partially form an internal cavity, wherein the semi-permeable component comprises a layer of confluent cells, and
coating the implantable bone structure in discrete locations with the one or more biologically active molecules to selectively at least partially modify bone restructuring.

### Claim 52 (depends on 51)

The method of claim 51, wherein the one or more biologically active molecules are designed to at least partially prevent restructuring of the implantable bone structure.

### Claim 53 (depends on 52)

The method of claim 52, wherein the one or more biologically active molecules are designed to at least partially enhance restructuring of the implantable bone structure.
